Accuray Incorporated (ARAY) reported third-quarter fiscal 2025 loss per share of a cent compared with the year-ago period’s loss of 6 cents. The bottom line surpassed the Zacks Consensus Estimate by 80%.ARAY’s Revenues in DetailAccuray registered quarterly revenues of $113.2 million, up 11.9% year over year. The figure beat the Zacks Consensus Estimate by 10.9%.The overall top-line growth was driven by robust growth in product revenue and solid demand for its CyberKnife system.ARAY’s shares moved south 4.3% ...

Accuray (ARAY) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 80%. A quarter ago, it was expected that this radiation oncology company would post a loss of $0.01 per share when it actually produced earnings of $0.02, delivering a surprise of 300%.Over the last four quarters, the company has ...

Q3'FY25 Earnings Call Supplemental Presentation April 30, 2025 Forward-looking Statements This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Safe Harbor Statement Statements in this presentation (including the oral commentary that accompanies it) that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in ...

Accuray (ARAY) Q3 2025 Earnings Call April 30, 2025 04:30 PM ET Speaker0 Good day, and welcome to the Accuray Third Quarter Fiscal twenty twenty five Financial Results Conference Call. All participants will be in a listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Jesse Chu, Chief Legal Officer. Please go ahead. Speaker1 Thank you, operator, and good afternoon, everyone. Welco ...

Exhibit 99.1 Accuray Reports Fiscal 2025 Third Quarter Financial Results MADISON, Wis, April 30, 2025 — Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2025. Key Fiscal Third Quarter Highlights: "We achieved a strong third quarter and I am proud of the resiliency of the entire team and their focus on driving actions to mitigate the impact of the tariffs. Despite evolving global dynamics, our team's disciplined execution, clear strategy and the growi ...

MADISON, Wis., April 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2025.Key Fiscal Third Quarter Highlights: Total net revenue was $113.2 million, an increase of 12 percent year-over-year Net loss was $1.3 million compared to a net loss of $6.3 million in the prior year period Adjusted EBITDA was $6.0 million compared to $1.1 million in the prior year period"We achieved a strong third quarter and I am proud of the resilien ...

Data Also Highlights Continued Clinical Advances Using the CyberKnife System That are Making High Quality Care an Option for People Who Previously Had Limited ChoicesMADISON, Wis., April 3, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data on the clinical use of the CyberKnife® System reinforce the device's broad-based radiation treatment capabilities for central nervous system (CNS) tumors. Malignant brain and other CNS tumors are considered to be some of the most fatal ...

MADISON, Wis., March 12, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the 37th Annual Roth Conference taking place on March 16 -18, 2025 in Dana Point, California.Management will participate in a fireside chat on Tuesday, March 18, 2025, at 9:30am PT / 12:30pm ET, and will be available for one-on-one meetings with investors.A live webcast of the fireside chat can be accessed here and on the Accuray website at investors.accuray.com. The webcast replay of the p ...

Accuray Incorporated (ARAY) is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust global performance in the second quarter of fiscal 2025 and potential in the Radiosurgery Market, is expected to contribute further. However, reimbursement uncertainties and challenges related to FX impacts are concerning.This Zacks Rank #3 (Hold) company has lost 26.3% in the past year compared with a 1.3% decline in the industry. The S&P 500 has wi ...

Accuray Incorporated (ARAY) reported second-quarter fiscal 2025 earnings per share of 2 cents against the year-ago period’s loss of 10 cents. The bottom line surpassed the Zacks Consensus Estimate by 300%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Revenues in DetailAccuray registered quarterly revenues of $116.2 million, up 8.3% year over year. The figure beat the Zacks Consensus Estimate by 4.7%.The overall top-line growth was driven by robust growth in product revenue and solid ...